REFERENCES
- Kliegman RM, Fanaroff AA. Necrotizing enterocolitis. New Engl J Med 1984;310:1093–1103.
- Uauy RD, Fanaroff AA, Korones SB, et al. Necrotizing enterocolitis in very low birth weight infants: Biodemographic and clinical correlates. J Pediatr 1991;119:630–8.
- Brown EG, Sweet AY. Neonatal necrotizing enterocolitis. Pediatr Clin North Am 1982;29:1149–70.
- Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Ann Surg 1978;187:1–7.
- Walsh MC, Kliegman RM. Necrotizing enterocolitis: Treatment based on staging criteria. Pediatr Clin North Am 1986;33:179–201.
- Abramo TJ, Evans JS, Kokomoor FW, Kantak AD. Occult blood in stools and necrotizing enterocolitis: Is there a relationship? Am J Dis Child 1988;142:451–2.
- Wilson R, Kanto WP, Jr, McCarthy BJ, et al. Epidemiologic characteristics of necrotizing enterocolitis: A population-based study. Am J Epidemiol 1981;114:880–7.
- Kliegman RM, Fanaroff AA. Neonatal necrotizing enterocolitis: A nine-year expérience II. Outcome assessment. Am J Dis Child 1981;135:608–11.
- Radhakrishnan J, Blechman G, Shrader C, et al. Colonie strictures following successful médical management of necrotizing enterocolitis: A prospective study evaluating early gastrointestinal contrast studies. J Pediatr Surg 1991;9:1043–46.
- Schullinger JN, Mollitt DL, Vinocur CD, Santulli TV, Driscoll JM, Jr. Neonatal necrotizing enterocolitis: Survival, management, and complications: A 25 year study. Am J Dis Child 1981; 135:612–4.
- Ballance WA, Dahms BB, Shenker N, Kliegman RM. Pathology of neonatal necrotizing enterocolitis: A ten-year expérience. J Pediatr 1990;117:S6–S13.
- Lawrence G, Walker PD. Pathogenesis of enteritis necroticans in Papua New Guinea. Lancet 1976; 1:125–6.
- Polin RA, Pollack PF, Barlow B, et al. Necrotizing enterocolitis in term infants. J Pediatr 1976; 89:460–2.
- Wiswell TE, Robertson CF, Jones TA, Tuttle DJ. Necrotizing enterocolitis in full-term infants: A case-control study. Am J Dis Child 1988;142:532–5.
- Malcolm G, Ellwood D, Deevonald K, Beilby R, Henderson-Smart D. Absent or reversed end dia-stolic flow velocity in the umbilical artery and necrotising enterocolitis. Arch Dis Child 1991;66:805–7.
- Costello S, Hellmann J, Lui K. Myelomeningocele: A risk factor for necrotizing enterocolitis in term infants. J Pediatr 1988;113:1041–43.
- Leung MP, Chau KT, Hui PW, et al. Necrotizing enterocolitis in neonates with symptomatic congénital heart disease. J Pediatr 1988;113:1044–46.
- Oldham KT, Coran AG, Drongowski RA, Baker PJ, Wesley JR, Polley TZ, Jr. The development of necrotizing enterocolitis following repair of gastroschisis: A surprisingly high incidence. J Pediatr Surg 1988;23:945–9.
- Czyrko C, Del Pin CA, O'Neill JA, Jr, Peckham GJ, Ross AJ III. Maternai cocaine abuse and necrotizing enterocolitis: Outcome and survival. J Pediatr Surg 1991;26:414–21.
- Udall JN, Jr. Gastrointestinal host défense and necrotizing enterocolitis. J Pediatr 1990; 117:S33–S43.
- Aynsley-Green A, Lucas A, Lawson GR, Bloom SR. Gut hormones and regulatory peptides in relation to enterai feeding, gastroenteritis, and necrotizing enterocolitis in infancy. J Pediatr 1990; 117:S24–S31.
- Nowicki PT, Miller CE. Autoregulation in the developing postnatal intestinal circulation. Am J Phys-iol 1988;254:G189–G193.
- Nowicki PT, Hansen NB, Hayes JR, Menke JA, Miller RR. Intestinal blood flow and 02 uptake during hypoxemia in the newborn piglet. Am J Physiol 1986;251:G19–G24.
- Udall JN, Pang K, Fritze L, Leinman R, Walker WA. Development of gastrointestinal mucosal bar-rier. I. The effect of âge on intestinal permeability to macromolecules. Pediatr Res 1981;15:241–4.
- Perkkio M, Savilahti E. Time of appearance of immunoglobulin-containing cells in the mucosa of the neonatal intestine. Pediatr Res 1980;14:953–5.
- Kliegman RM, Fanaroff AA. Neonatal necrotizing enterocolitis: A nine-year expérience. I. Epidemi-ology and uncommon observations. Am J Dis Child 1981;135:603–7.
- Brown EG, Sweet AY. Preventing necrotizing enterocolitis in neonates. J Am Med Assoc 1978; 240:2452–4.
- deLemos R.A, Rogers J.H McLaughlin W. Expérimental production of necrotizing enterocolitis in newborn goats. Pediatr Res 1974;8:380(abstract).
- Crissinger KD, Granger DN. Mucosal injury induced by ischemia and reperfusion in the piglet intestine: Influences of âge and feeding. Gastroenterology 1989;97:920–6.
- Lawrence G, BatesJ, Gaul A. Pathogenesis of neonatal necrotising enterocolitis. Lancet 1982;1:137–9.
- Beeby PJ, Jeffery H. Risk factors for necrotising enterocolitis: The influence of gestational âge. Arch Dis Child 1992;67:432–5.
- Stoll BJ, Kanto WPJr, Glass RI, Nahmias AJ, Brann AWJr. Epidemiology of necrotizing enterocolitis: A case control study. J Pediatr 1980;96:447–51.
- Touloukian RJ, Posch JN, Spencer R. The pathogenesis of ischémie gastroenterocolitis of the neonate: Sélective gut mucosal ischemia in asphyxiated neonatal piglets. J Pediatr Surg 1972;7:194–205.
- Hansbrough F, Priebe CJ Jr, Falterman KW, Bornside GH, Welsh RA. Pathogenesis of early necrotizing enterocolitis in the hypoxic neonatal dog. Am J Surg 1983;145:169–75.
- Harrison MW, Connell RS, Campbell JR, Webb MC. Fine structural changes in the gastro-intestinal tract of the hypoxic puppy: A study of natural history. J Pediatr Surg 1977;12:403–8.
- Brown RA, Chiu CJ, Scott HJ, Gurd FN. Ultrastructural changes in the canine ileal mucosal cell after mesenteric arterial occlusion: A sequential study. Arch Surg 1970;101:290–7.
- Barlow B, Santulli TV, Heird WC, Pitt J, Blanc WA, Schullinger JN. An expérimental study of acute neonatal enterocolitis—the importance of breast milk. J Pediatr Surg 1974;9:587–94.
- KJiegman RM. Neonatal necrotizing enterocolitis: Implications for an infectious disease. Pediatr Clin North Am 1979;26:327–44.
- Kosloske AM, Ulrich JA. A bactériologie basis for the clinical présentations of necrotizing enterocolitis. J Pediatr Surg 1980;15:558–64.
- Hoy C, Millar MR, MacKay P, Godwin PGR, Langdale V, Levene MI. Quantitative changes in faecal microflora preceding necrotising enterocolitis in prématuré neonates. Arch Dis Child 1990; 65:1057–9.
- Guinan M, Schaberg D, Bruhn FW, Richardson J, Fox WW. Epidémie occurrence of neonatal necrotizing enterocolitis. Am J Dis Child 1979;133:594–7.
- Natanson C, Eichenholz PW, Danner RL, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989;169:823–32.
- Scheifele DW, Olsen E, Fussell S, Pendray M. Spontaneous endotoxinemia in prématuré infants: Corrélations with oral feeding and bowel dysfunction. J Pediatr Gastroenterol Nutr 1985;4:67–74.
- Demling RH, Lalonde CC, Li-Juan J, Albes J, Fiori N. The pulmonary and systemic response to récurrent endotoxemia in the adult sheep. Surgery 1986;100:876–83.
- Terashita ZI, Imura Y, Nishikawa K, Suraida S. Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur J Pharmacol 1985;109:257–61.
- Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470–4.
- Okusawa S, Gelfand JA, Ikejima T, Conolly RJ, Dinarello CA. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988;81:1162–72.
- Sun XM, Hsueh W. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 1988;81:1328–31.
- Hanahan DJ. Platelet activating factor: A biologically active phosphoglyceride. Ann Rev Biochem 1986;55:483–509.
- Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259:C697–708.
- Farr RS, Wardlow ML, Cox CP, Meng KE, Greene DE. Human sérum acid-labile factor is an acyl-hydrolase that inactivates platelet-activating factor. Fédération Proc 1983;42:3120–2.
- Doebber TW, Wu MS, Robbins JC, Choy BM, Chang MN, Shen TY. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kad-surenone. Biochem Biophys Res Comm 1985;127:799–808.
- Gonzalez-Crussi F, Hsueh W. Expérimental model of ischémie bowel necrosis: The rôle of platelet-activating factor and endotoxin. Am J Pathol 1983;112:127–35.
- Hsueh W, Gonzalez-Crussi F, Arroyave JL. Platelet activating factor is an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1987;1:403–5.
- Hsueh W, Gonzalez-Crussi F, ArroyaveJL, Anderson RC, Lee ML, Houlihan WJ. Platelet activating factor-induced ischémie bowel necrosis: The effect of PAF antagonists. Eur J Pharmacol 1986; 123:79–83.
- Caplan MS, Sun SM, Hsueh W. Hypoxia causes ischémie bowel necrosis in rats: The rôle of platelet-activating factor (PAF-acether). Gastroenterology 1990;99:979–986.
- Caplan MS, Kelly A, Hsueh W. Endotoxin and hypoxia-induced intestinal necrosis in rats: The rôle of platelet activating factor. Pediatr Res 1992;31:428–34.
- Caplan MS, Sun XM, Hsueh W, Hageman JR. Rôle of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990;116:960–4.
- Caplan M, Hsueh W, Kelly A, Donovan M. Sérum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 1990;39:705–14.
- Denizot Y, Benveniste J. Contamination of fermented milk products by proinflammatory autacoid PAF-acether. Comptes Rendus De L Académie Des Sciences (French) 1989;309:593–7.
- Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336:1519–23.
- Bauer CR, Morrison JO, Poole KW, et al. A decreased incidence of necrotizing enterocolitis after prénatal glucocorticoid therapy. Pediatrics 1984;73:682–8.
- Halac E, Halac J, Bègue EF, et al. Prénatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: A controlled trial. J Pediatr 1990;117:132–8.
- Ng PC, Dear PRF, Thomas DFM. Oral vancomycin in prévention of necrotising enterocolitis. Arch DisChild 1988;63:1390–3.
- Egan EA, Mantilla G, Nelson RM, Eitzman DV. A prospective controlled trial of oral kanamycin in the prévention of neonatal necrotizing enterocolitis. J Pediatr 1976;89:467–70.
- Grylack LJ, Scanlon JW. Oral gentamicin therapy in the prévention of neonatal necrotizing enterocolitis. A controlled double-blind trial. Am J Dis Child 1978;132:1192–4.
- Eibl MM, Wolf HM, Furnkranz H, Rosenkranz A. Prévention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N Engl J Med 1988;319:1–7.
- Goldman AS, Smith CW. Host résistance factors in human milk. J Pediatr 1973;83:1082–6.
- Kliegman RM, Pittard WB, Fanaroff AA. Necrotizing enterocolitis in neonates fed human milk. J Pediatr 1979;95:450–3.
- Moriartey RR, Finer NN, Cox SF, et al. Necrotizing enterocolitis and human milk. J Pediatr 1979; 94:295–6.
- McDonald MC, Henning SJ. Synergistic effects of thyroxine and dexamethasone on enzyme ontogeny in rat small intestine. Pediatr Res 1992;32:306–11.
- Kedinger M, Simon PM, Raul F, Grenier JF, Haffen K. The effect of dexamethasone on the develop-ment of rat intestinal brush border enzymes in organ culture. Dev Biol 1980;74:9–21.
- Rubaltelli FF, Benini F, Sala M. Prévention of necrotizing enterocolitis in neonates at risk by oral-administration of monomeric IgG. Dev Pharmacol Ther 1991;17:138–43.
- Pinquier JL, Sedivy P, Bruno R, et al. Inhibition of ex-vivo PAF-induced platelet aggregation by the PAF-antagonist RP 48740: Relationship to plasma concentrations in healthy volunteers. Eur J Clin Pharmacol 1991;41:141–5.
- Roberts NM, McCusker M, Chung KF, Barnes PJ. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects. Br J Clin Pharmacol 1988;26:65–72.